Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2018-04-18 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
独立董事关于第一届董事会第二十二次会议有关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion report from independent directors regarding various matters discussed at the 22nd meeting of the first board of directors of the company. It covers topics such as the 2017 profit distribution plan, the use of raised funds, audit firm reappointment, internal control evaluation, use of idle funds, remuneration plans for 2018, and accounting policy changes. The document is not a full annual report or audit report but rather an independent directors' opinion on board meeting matters, including financial and governance issues. It is not a short announcement or certification but a detailed opinion document related to board/management matters. Therefore, the most appropriate classification is Board/Management Information (MANG).
2018-04-18 Chinese
2017年年度审计报告
Regulatory Filings
2018-04-18 Chinese
2017年度独立董事述职报告（宋瑞霖）
Management Reports Classification · 95% confidence The document is titled as the "2017年度独立董事述职报告" which translates to "2017 Annual Independent Director's Work Report". It details the independent director's attendance at board meetings, shareholder meetings, committee meetings, opinions on various company matters including financial reports, audit reports, internal controls, related party transactions, and other governance issues for the year 2017. The content is a detailed management report on the independent director's duties and opinions rather than a full annual report or audit report. It is not a transcript, capital update, or any other category. This fits best under Management Reports (MDA), which cover management's detailed explanation of financial results, business trends, and outlook, including governance and oversight activities by management or directors. The document length is over 10,000 characters and contains substantive content, not just an announcement or certification, so it is not RPA or RNS. Therefore, the classification is MDA with high confidence.
2018-04-18 Chinese
华西证券股份有限公司关于公司2017年度保荐工作报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2017年度保荐工作报告" which translates to "2017 Annual Sponsorship Work Report" by 华西证券股份有限公司 for 西藏易明西雅医药科技股份有限公司. It details the sponsorship work overview, supervision of company governance, information disclosure, fundraising supervision, and various commitments and promises by company directors and shareholders. The content is focused on the sponsor's review and oversight activities related to the company, including compliance with regulations, internal controls, and shareholder commitments. It does not contain financial statements or quarterly/annual financial results, nor is it a transcript, presentation, or announcement of voting results. It is a detailed report on the sponsor's work and findings, which aligns with the category of Audit Report / Information (AR), as it relates to regulatory oversight and compliance reporting by the sponsor, not the full annual report or earnings release. The document length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement or certification. Therefore, the best fitting classification is AR (Audit Report / Information). FY 2017
2018-04-18 Chinese
关于使用部分闲置募集资金和自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a listed company regarding the use of idle raised funds and own funds for cash management. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, details board and supervisory approvals, and includes information on investment amounts, types, and risk controls. The document is structured as a formal public announcement about a financing and capital management activity, specifically the use of idle raised funds for investment in low-risk financial products. It does not contain financial statements or comprehensive financial performance data, nor is it a transcript, report, or voting result. The content fits the category of a Capital/Financing Update, as it informs shareholders and the market about the company's capital management decisions and use of funds.
2018-04-18 Chinese
2017年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled as the "2017 年度董事会工作报告" which translates to "2017 Annual Board of Directors Work Report." It reviews the company's overall business performance in 2017, details the board's work during the year, including governance, internal controls, shareholder meetings, and committee activities, and outlines the board's plans for 2018. The content focuses on the board's activities and governance rather than full financial statements or audit results. The document length is 3562 characters, which is relatively short and consistent with a board/management report rather than a full annual report or audit report. There is no indication that this is a presentation, voting results, or a regulatory filing. Therefore, the document best fits the category of Board/Management Information (MANG).
2018-04-18 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.